Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer

BACKGROUND: Thyroid transcription factor-1 (TTF-1) is expressed in approximately 70% of lung adenocarcinomas and is one of the most reliable makers to distinguish primary lung adenocarcinoma from metastatic disease. TTF-1-negative status is a poor prognostic factor, and TTF-1-negative lung adenocarc...

Descripción completa

Detalles Bibliográficos
Autores principales: Iso, Hirokazu, Hisakane, Kakeru, Mikami, Erika, Suzuki, Takahiro, Matsuki, Satoru, Atsumi, Kenichiro, Nagata, Kohji, Seike, Masahiro, Hirose, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579824/
https://www.ncbi.nlm.nih.gov/pubmed/37854151
http://dx.doi.org/10.21037/tlcr-23-331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579824/
https://www.ncbi.nlm.nih.gov/pubmed/37854151
http://dx.doi.org/10.21037/tlcr-23-331

Ejemplares similares